Cargando…

Molecular mechanism of Ruxian Shuhou prescription in the treatment of triple-negative breast cancer based on network pharmacology

We aimed to explore the molecular mechanism of Ruxian Shuhou prescription in the treatment of triple-negative breast cancer (TNBC) by using network pharmacology. The active components and targets of the prescription were obtained by Traditional Chinese medicine systems pharmacology database. Gencard...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chu, Meiling, Meng, Tian, Zhou, Yue, Jin, Lan, Dai, Qiuying, Ma, Lina, Chen, Hongfeng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2023
Materias:	5700
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10476815/ https://www.ncbi.nlm.nih.gov/pubmed/37657065 http://dx.doi.org/10.1097/MD.0000000000034763

Ejemplares similares

A three-long noncoding RNA signature as a diagnostic biomarker for differentiating between triple-negative and non-triple-negative breast cancers
por: Liu, Man, et al.
Publicado: (2017)

Metaplastic Breast Carcinoma Versus Triple-Negative Breast Cancer: Survival and Response to Treatment
por: Aydiner, Adnan, et al.
Publicado: (2015)

Trends of triple negative breast cancer research (2007–2015): A bibliometric study
por: Wang, Yiran, et al.
Publicado: (2016)

Integrative exploration of genomic profiles for triple negative breast cancer identifies potential drug targets
por: Wang, Xiaosheng, et al.
Publicado: (2016)

Vinorelbine Plus Platinum in Patients with Metastatic Triple Negative Breast Cancer and Prior Anthracycline and Taxane Treatment
por: li, Meiying, et al.
Publicado: (2015)

Effect of Bicalutamide on the proliferation and invasion of human triple negative breast cancer MDA-MB-231 cells
por: Kong, Yan, et al.
Publicado: (2020)

MicroRNA-496 inhibits triple negative breast cancer cell proliferation by targeting Del-1
por: Lee, Soo Jung, et al.
Publicado: (2021)

Aldehyde dehydrogenase 1 (ALDH1) expression is an independent prognostic factor in triple negative breast cancer (TNBC)
por: Ma, Fei, et al.
Publicado: (2017)

Network pharmacology to explore the molecular mechanisms of Prunella vulgaris for treating thyroid cancer
por: Zhang, Zhiqiang, et al.
Publicado: (2023)

Anti-Nasopharyngeal carcinoma mechanism of sanguinarine based on network pharmacology and molecular docking
por: Fan, Jing-Ying, et al.
Publicado: (2023)

MRI-based radiomics approach for the prediction of recurrence-free survival in triple-negative breast cancer after breast-conserving surgery or mastectomy
por: Zhao, Jingwei, et al.
Publicado: (2023)

Prognostic factors and treatment outcomes in patients with non-ampullary small bowel adenocarcinoma: Long-term analysis
por: Tian, Jiangfang, et al.
Publicado: (2019)

Determining the mechanism of action of the Qishan formula against lung adenocarcinoma by integration of network pharmacology, molecular docking, and proteomics
por: Geng, Xue, et al.
Publicado: (2023)

Liver Metastasis of a Triple-Negative Breast Cancer and Complete Remission for 5 Years After Treatment With Combined Bevacizumab/Paclitaxel/Carboplatin: Case Report and Review of the Literature
por: Ogata, Hideaki, et al.
Publicado: (2015)

Pharmacological effect and mechanism of orlistat in anti-tumor therapy: A review
por: Hao, Xiaoqing, et al.
Publicado: (2023)

A randomized phase II trial comparing capecitabine with oxaliplatin or docetaxel as first-line treatment in advanced gastric and gastroesophageal adenocarcinomas
por: Ni, Lu, et al.
Publicado: (2021)

The mechanism of Bai He Gu Jin Tang against non-small cell lung cancer revealed by network pharmacology and molecular docking
por: Xie, Rui-fei, et al.
Publicado: (2022)

Integrated bioinformatics and network pharmacology to explore the therapeutic target and molecular mechanisms of Taxus chinensis against non-small cell lung cancer
por: Zhang, Shujuan, et al.
Publicado: (2023)

The molecular mechanisms of celecoxib in tumor development
por: Wen, Bin, et al.
Publicado: (2020)

Network analysis to explore the pharmacological mechanism of Shenmai injection in treating granulocytopenia and evidence-based medicine approach validation
por: Hou, Xianbing, et al.
Publicado: (2023)

Diagnosis of Breast Hyperplasia and Evaluation of RuXian-I Based on Metabolomics Deep Belief Networks
por: Jiang, Mingyang, et al.
Publicado: (2019)

ALK-negative lung inflammatory myofibroblastic tumor in a young adult: A case report and literature review of molecular alterations
por: Debonis, Silvia Angela, et al.
Publicado: (2021)

Identification of potential biomarkers and candidate therapeutic drugs for clear cell renal cell carcinoma by bioinformatic analysis and reverse network pharmacology
por: Meng, Zhuo, et al.
Publicado: (2023)

A real-world study of recombinant human endostatin combined with PD-1/PD-L1 blockade and chemotherapy for patients with advanced non-small cell lung cancer negative for actionable molecular biomarkers
por: Zhao, Jing-Wen, et al.
Publicado: (2023)

A network pharmacology-based investigation of emodin against pancreatic adenocarcinoma
por: Shi, Xueying, et al.
Publicado: (2023)

Mechanism of morusin on breast cancer via network pharmacology and in vitro experiments
por: Li, Hangzhen, et al.
Publicado: (2023)

Negative Impact of Preoperative Platelet-Lymphocyte Ratio on Outcome After Hepatic Resection for Intrahepatic Cholangiocarcinoma
por: Chen, Qing, et al.
Publicado: (2015)

Different histological types of triple metachronous primary lung carcinomas in 1 patient: Case report
por: Kim, Jee Hyuk, et al.
Publicado: (2017)

The model of descriptive, diagnostic, predictive, and prescriptive analytics on 100 top-cited articles of nasopharyngeal carcinoma from 2013 to 2022: Bibliometric analysis
por: Hung, Chung-Chia, et al.
Publicado: (2023)

Investigation of target genes and potential mechanisms related to compound Xiao-ai-fei honey ointment based on network pharmacology and bioinformatics analysis
por: Abudurousuli, Kayisaier, et al.
Publicado: (2023)

The mechanism of dehydroandrographolide inhibiting metastasis in gastric cancer based on network pharmacology and bioinformatics
por: Luo, Yan-hai, et al.
Publicado: (2023)

Triple metachronous primary cancer of uterus, colon, and breast cancer: A case report and review of the literature
por: Li, Guanqiao, et al.
Publicado: (2020)

Network pharmacology-based strategy for predicting therapy targets of Ecliptae Herba on breast cancer
por: Li, Hui, et al.
Publicado: (2023)

Human immunodeficiency virus-negative plasmablastic lymphoma: A case report and literature review
por: Lin, Li, et al.
Publicado: (2017)

The feasibility of using the compound kushen injection to treat cervical cancer based on network pharmacology and transcriptomics
por: Zhang, Yiting, et al.
Publicado: (2023)

Protective effect of hawthorn vitexin on the ethanol-injured DNA of BRL-3A hepatocytes
por: Ding, Chengshi, et al.
Publicado: (2021)

Long-term survival in a patient with advanced non-smoking lung adenocarcinoma and no EGFR mutation after comprehensive therapy with EGFR-TKI-based therapy: A case report
por: Zhang, Qianyu, et al.
Publicado: (2022)

First-line pemetrexed and carboplatin plus anlotinib for epidermal growth factor receptor wild-type and anaplastic lymphoma kinase-negative lung adenocarcinoma with brain metastasis: A case report and review of the literature
por: Zhang, Chu, et al.
Publicado: (2020)

Musashi1 expression is negatively correlated with numb expression in brain metastases
por: Dong, Yalan, et al.
Publicado: (2020)

The association of hepatitis B virus screening and antiviral prophylaxis with adverse liver outcomes in Chinese cancer patients undergoing chemotherapy: A retrospective study
por: He, Lan-Ying, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_dga6ib77r7b80l07bocpgs9eru